Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Uncover effective ways to cut expenses and save more money each month. Small changes can lead to significant savings over time.
27,238 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A massive block of XRP options trades points to a bet that Ripple stays in a tight range through June, potentially an...
Bitcoin faces renewed pressure around the $60,000 zone with on-chain data suggesting more coins moving to exchanges. ...
AVUV has climbed this year, but rate expectations and bank exposure keep its outlook uncertain. Here’s what AVUV inve...
The U.S. confirms the death of a service member amid renewed clashes in the Middle East. Families and investors face ...
Cardano’s ADA retreated about 11% month-to-date, pushing buyers to defend a trio of critical supports. Analysts outli...
The AI stock story is shifting from last year’s heroes to new winners in 2026. This guide explains why the leadership...
The day brought a notable jump in the QBTS stock as headlines pointed to potential funding. This guide breaks down wh...
When billionaire Dalio just warned about AI hype, it sparked a wider discussion on valuations and risk. This guide ex...
A fresh industry snapshot shows the typical enterprise AI outlay hits $11.5 million per year, but most firms cannot d...
The House backed a bill to ease banking rules for community lenders, a move that could reshape mortgage lending and m...
As markets wobble in early 2026, a handful of Dow Jones dividend stocks offer reliable income for retirees. This repo...